CD44 deficiency is associated with enhanced Escherichia coli-induced proinflammatory cytokine and chemokine release by peritoneal macrophages

Infection and Immunity

Volumn 78, Issue 1, 2010, Pages 115-124

  Van Der Windt, Gerritje J W ^a   Van 't Veer, Cornelis ^a   Florquin, Sandrine ^a   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CHEMOKINE; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1; PERITONEAL DIALYSIS FLUID; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN FUNCTION; ARTICLE; CELL STIMULATION; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE RELEASE; ESCHERICHIA COLI; EX VIVO STUDY; IMMUNE RESPONSE; KNOCKOUT MOUSE; LEUKOCYTE; MACROPHAGE ACTIVATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; ORGAN INJURY; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEPSIS; SERUM; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; ANTIGENS, CD44; CYTOKINES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENE EXPRESSION REGULATION; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERITONITIS; TIME FACTORS;

EID: 73449119607     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00949-09     Document Type: Article

References (47)

1. Alstergren, P., B. Zhu, M. Glogauer, T. W. Mak, R. P. Ellen, and J. Sodek. 2004. Polarization and directed migration of murine neutrophils is dependent on cell surface expression of CD44. Cell. Immunol. 231:146-157.
2. Billadeau, D. D. 2008. PTEN gives neutrophils direction. Nat. Immunol. 9:716-718.
3. Broche, F., and J. M. Tellado. 2001. Defense mechanisms of the peritoneal cavity. Curr. Opin. Crit. Care 7:105-116.
4. DeGrendele, H. C., P. Estess, and M. H. Siegelman. 1997. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278:672-675.
5. Foxman, E. F., J. J. Campbell, and E. C. Butcher. 1997. Multistep navigation and the combinatorial control of leukocyte chemotaxis. J. Cell Biol. 139: 1349-1360.
6. Foxman, E. F., E. J. Kunkel, and E. C. Butcher. 1999. Integrating conflicting chemotactic signals. The role of memory in leukocyte navigation. J. Cell Biol. 147:577-588.
7. Fraser, J. R., T. C. Laurent, and U. B. Laurent. 1997. Hyaluronan: its nature, distribution, functions and turnover. J. Intern. Med. 242:27-33.
8. Gee, K., M. Kryworuchko, and A. Kumar. 2004. Recent advances in the regulation of CD44 expression and its role in inflammation and autoimmune diseases. Arch. Immunol. Ther. Exp. (Warsz.) 52:13-26.
9. Giebelen, I. A., A. Le Moine, P. S. van den Pangaart, C. Sadis, M. Goldman, S. Florquin, and T. van der Poll. 2008. Deficiency of alpha7 cholinergic receptors facilitates bacterial clearance in Escherichia coli peritonitis. J. Infect. Dis. 198:750-757.
10. Gonda, A., I. Gal, S. Szanto, B. Sarraj, T. T. Glant, J. Hunyadi, and K. Mikecz. 2005. CD44, but not l-selectin, is critically involved in leucocyte migration into the skin in a murine model of allergic dermatitis. Exp. Dermatol. 14:700-708.
11. Hau, T. 1990. Bacteria, toxins, and the peritoneum. World J. Surg. 14:167-175.
12. Heit, B., S. M. Robbins, C. M. Downey, Z. Guan, P. Colarusso, B. J. Miller, F. R. Jirik, and P. Kubes. 2008. PTEN functions to 'prioritize' chemotactic cues and prevent 'distraction' in migrating neutrophils. Nat. Immunol. 9:743-752.
13. Hollingsworth, J. W., Z. Li, D. M. Brass, S. Garantziotis, S. H. Timberlake, A. Kim, I. Hossain, R. C. Savani, and D. A. Schwartz. 2007. CD44 regulates macrophage recruitment to the lung in lipopolysaccharide-induced airway disease. Am. J. Respir. Cell Mol. Biol. 37:248-253.
14. Hotchkiss, R. S., and I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348:138-150.
15. Isacke, C. M., and H. Yarwood. 2002. The hyaluronan receptor, CD44. Int. J. Biochem. Cell Biol. 34:718-721.
16. Jann, K., and B. Jann. 1987. Polysaccharide antigens of Escherichia coli. Rev. Infect. Dis. 9(Suppl. 5):S517-S526.
17. Jiang, H., R. S. Peterson, W. Wang, E. Bartnik, C. B. Knudson, and W. Knudson. 2002. A requirement for the CD44 cytoplasmic domain for hyaluronan binding, pericellular matrix assembly, and receptor-mediated endocytosis in COS-7 cells. J. Biol. Chem. 277:10531-10538.
18. Johnson, P., A. Maiti, K. L. Brown, and R. Li. 2000. A role for the cell adhesion molecule CD44 and sulfation in leukocyte-endothelial cell adhesion during an inflammatory response? Biochem. Pharmacol. 59:455-465.
19. Katayama, Y., A. Hidalgo, J. Chang, A. Peired, and P. S. Frenette. 2005. CD44 is a physiological E-selectin ligand on neutrophils. J. Exp. Med. 201: 1183-1189.
20. Katoh, S., N. Matsumoto, K. Kawakita, A. Tominaga, P. W. Kincade, and S. Matsukura. 2003. A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia. J. Clin. Invest. 111:1563-1570.
21. Katoh, S., J. B. McCarthy, and P. W. Kincade. 1994. Characterization of soluble CD44 in the circulation of mice. Levels are affected by immune activity and tumor growth. J. Immunol. 153:3440-3449.
22. Katoh, S., Z. Zheng, K. Oritani, T. Shimozato, and P. W. Kincade. 1995. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med. 182:419-429.
23. Kawana, H., H. Karaki, M. Higashi, M. Miyazaki, F. Hilberg, M. Kitagawa, and K. Harigaya. 2008. CD44 suppresses TLR-mediated inflammation. J. Immunol. 180:4235-4245.
24. Knapp, S., A. F. de Vos, S. Florquin, D. T. Golenbock, and T. van der Poll. 2003. Lipopolysaccharide binding protein is an essential component of the innate immune response to Escherichia coli peritonitis in mice. Infect. Immun. 71:6747-6753.
25. Knapp, S., U. Matt, N. Leitinger, and T. van der Poll. 2007. Oxidized phospholipids inhibit phagocytosis and impair outcome in gram-negative sepsis in vivo. J. Immunol. 178:993-1001.
26. Leemans, J. C., S. Florquin, M. Heikens, S. T. Pals, R. van der Neut, and T. Van Der Poll. 2003. CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis. J. Clin. Invest. 111:681-689.
27. Liang, J., D. Jiang, J. Griffith, S. Yu, J. Fan, X. Zhao, R. Bucala, and P. W. Noble. 2007. CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages. J. Immunol. 178:2469-2475.
28. Liew, F. Y., D. Xu, E. K. Brint, and L. A. O'Neill. 2005. Negative regulation of Toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5:446-458.
29. Lorber, B., and R. M. Swenson. 1975. The bacteriology of intra-abdominal infections. Surg. Clin. N. Am. 55:1349-1354.
30. Lupberger, J., K. A. Kreuzer, G. Baskaynak, U. R. Peters, P. le Coutre, and C. A. Schmidt. 2002. Quantitative analysis of beta-actin, beta-2-microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT-PCR. Mol. Cell. Probes 16:25-30.
31. McColl, S. R., and I. Clark-Lewis. 1999. Inhibition of murine neutrophil recruitment in vivo by CXC chemokine receptor antagonists. J. Immunol. 163:2829-2835.
32. McDonald, B., E. F. McAvoy, F. Lam, V. Gill, C. de la Motte, R. C. Savani, and P. Kubes. 2008. Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. J. Exp. Med. 205:915-927.
33. Medzhitov, R., and C. Janeway, Jr. 2000. Innate immunity. N. Engl. J. Med. 343:338-344.
34. Nathens, A. B. 2001. Relevance and utility of peritoneal cultures in patients with peritonitis. Surg. Infect. (Larchmt.) 2:153-162.
35. Panaro, M. A., and V. Mitolo. 1999. Cellular responses to FMLP challenging: a mini-review. Immunopharmacol. Immunotoxicol. 21:397-419.
36. Ponta, H., L. Sherman, and P. A. Herrlich. 2003. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell Biol. 4:33-45.
37. Puré, E., and C. A. Cuff. 2001. A crucial role for CD44 in inflammation. Trends Mol. Med. 7:213-221.
38. Renckens, R., J. J. Roelofs, S. Florquin, A. F. de Vos, J. M. Pater, H. R. Lijnen, P. Carmeliet, C. van 't Veer, and T. van der Poll. 2006. Endogenous tissue-type plasminogen activator is protective during Escherichia coli-induced abdominal sepsis in mice. J. Immunol. 177:1189-1196.
39. Rouschop, K. M., M. Sylva, G. J. Teske, I. Hoedemaeker, S. T. Pals, J. J. Weening, T. van der Poll, and S. Florquin. 2006. Urothelial CD44 facilitates Escherichia coli infection of the murine urinary tract. J. Immunol. 177:7225-7232.
40. Schmits, R., J. Filmus, N. Gerwin, G. Senaldi, F. Kiefer, T. Kundig, A. Wakeham, A. Shahinian, C. Catzavelos, J. Rak, C. Furlonger, A. Zakarian, J. J. Simard, P. S. Ohashi, C. J. Paige, J. C. Gutierrez-Ramos, and T. W. Mak. 1997. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 90:2217-2233.
41. Teder, P., R. W. Vandivier, D. Jiang, J. Liang, L. Cohn, E. Puré, P. M. Henson, and P. W. Noble. 2002. Resolution of lung inflammation by CD44. Science 296:155-158.
42. Thankamony, S. P., and W. Knudson. 2006. Acylation of CD44 and its association with lipid rafts are required for receptor and hyaluronan endocytosis. J. Biol. Chem. 281:34601-34609.
43. van Westerloo, D. J., I. A. Giebelen, S. Florquin, J. Daalhuisen, M. J. Bruno, A. F. de Vos, K. J. Tracey, and T. van der Poll. 2005. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J. Infect. Dis. 191:2138-2148.
44. van Zoelen, M. A., A. M. Schmidt, S. Florquin, J. C. Meijers, R. de Beer, A. F. de Vos, P. P. Nawroth, A. Bierhaus, and T. van der Poll. 2009. Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice. J. Infect. Dis. 200:765-773.
45. Wang, Q., P. Teder, N. P. Judd, P. W. Noble, and C. M. Doerschuk. 2002. CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice. Am. J. Pathol. 161:2219-2228.
46. Wheeler, A. P., and G. R. Bernard. 1999. Treating patients with severe sepsis. N. Engl. J. Med. 340:207-214.
47. Wuyts, A., A. Haelens, P. Proost, J. P. Lenaerts, R. Conings, G. Opdenakker, and J. Van Damme. 1996. Identification of mouse granulocyte chemotactic protein-2 from fibroblasts and epithelial cells. Functional comparison with natural KC and macrophage inflammatory protein-2. J. Immunol. 157:1736-1743.